Skip to content

Fascial Distortion Model Manual Therapy and Painful Shoulder Syndrome

Fascial Distortion Model Manual Therapy and Painful Shoulder Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03521778
Acronym
FDM
Enrollment
90
Registered
2018-05-11
Start date
2018-05-25
Completion date
2020-12-31
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain

Brief summary

Relatively new method of diagnosing and treating dysfunction of the musculoskeletal system is Fascial Distortion Model. It is manual therapy developed by emergency physician and an osteopath Stephen P. Typaldos. Disfunction are diagnosed based on verbal and physical descriptions, palpations, anamnesis. As a result of examination, It can be found one or more of six different distortions. The aim of the study is to examine the effectiveness of FDM manual therapy in comparison to manual therapy using the Mulligan Concept method and traditional physiotherapy in patients with shoulder dysfunction who have undergone previous rehabilitation and who have not achieved satisfactory results. Patients will receive five treatments with one day brake between each treatment. The patient's condition will be evaluated before the first treatment, two weeks after the last treatment, and also after three months. As a outcome of the occurring phenomenon, structural changes are planned at the level of the fascial system in the studied region. The obtained results may influence the current views on diseases of the musculoskeletal system, as well as on the method of diagnosing and treating shoulder joint dysfunction.

Interventions

Patients will receive manual treatment according to FDM procedures: 1. Triggerbands - therapist put a pressure by the thumb along the presented pathway. 2. Continuum Distortions - therapist put a pressure by the thumb at the exact place of feeling of pain. 3. Folding Distortions - therapist conduct traction or compression of the affected joint. 4. Herniated Triggerpoint - therapist put a pressure by the thumb at the place where HTP occurs. 5. Cylinder Distortions - therapist compress and stretch by the hands affected area. 6. Tectonic Fixation - Therapist compress and stretch affected area by the hands or tools like vacuum bubble.

Patients will receive manual treatment according to Mulligan Concept procedures: MWM- Mobilization With Movement- application can be defined as the application of a sustained passive force/glide. NAG - Natural Apophyseal Glide - application can be defined as the oscillatory mobilization techniques from the middle to the end of the range of motion. SNAG- Sustained Natural Apophyseal Glide- They are weight bearing techniques: all procedures are done with the patient sitting or in standing. They are mobilisations with active movement followed by passive over pressure.

OTHERTraditional physiotherapy

Patients will receive traditional physiotherapy: Exercises, laser treatment, magnetic field therapy, ultrasound treatment, light treatment

Sponsors

Józef Piłsudski University of Physical Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 86 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of dysfunction in the shoulder joint based on an orthopedic and/or physiotherapeutic examination confirmed by X-ray and ultrasound imaging, * patients undergoing prior rehabilitation / pharmacotherapy / surgical intervention without satisfactory results, * limitation of mobility and / or pain in the shoulder complex,

Exclusion criteria

* coexistence of neoplastic diseases, * symptoms from the cervical spine * pregnancy, * aneurysms, * osteitis, * arthritis * deep veins thrombosis of upper limbs, * resignation from the study / therapy, * skin damage, hematomas.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline DASH Outcome Measure at 3 months1'st day, 2 weeks after treatment, 3 months after treatmentThe Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure is a 30-item, self-report questionnaire designed to measure physical function and symptoms in patients with any or several musculoskeletal disorders of the upper limb. It helps describe the disability experienced by people with upper-limb disorders and also to monitor changes in symptoms and function over time .The DASH is scored in 30 items from 1 to 5. Higher score means greater level of disability.
Change from baseline Constant-Murley Shoulder Outcome Score at 3 months1'st day, 3 months after treatmentThe Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient.\[1\] The Constant-Murley score was introduced to determine the functionality after the treatment of a shoulder injury. The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher score, the higher the quality of the function.
Change from baseline Quality Of Life Questionnaire SF- 36v2 at 3 months1'st day, 3 months after treatmentThe SF-36 is a 36 item questionnaire that measures eight multi-item dimensions of health: physical functioning (10 items) social functioning (2 items) role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), energy/vitality (4 items), pain (2 items), and general health perception (5 items).
Change from baseline Visual Analogue Scale at 3 months1'st day, 3 months after treatmentVisual analogue scales (score 0-10) are psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients and use this to achieve a rapid classification of symptom severity and disease control. The higher score, indicate greater level of pain.

Contacts

Primary ContactAdrian Rogala, MSc
adrian.kamil.rogala@gmail.com537067960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026